Institutional Profile: Pharmacogenomic research in R Stephanie Huang Laboratory
- PMID:28290771
- DOI: 10.2217/pgs-2017-0031
Institutional Profile: Pharmacogenomic research in R Stephanie Huang Laboratory
Abstract
The Huang Lab was established in 2009 at the University of Chicago and has since been active in conducting pharmacogenomic research. Our laboratory's main research focus is translational pharmacogenomics with a particular interest in the pharmacogenomics of anticancer agents. By systematically evaluating the human genome and its relationships to drug response and toxicity, our goal is to develop clinically useful models that predict risk for adverse drug reactions and nonresponse prior to administration of chemotherapy. Specifically, the theme of our research evolved around the idea of cell-based pharmacogenomics, which utilizes in vitro models for biomarker discovery and prediction-model construction, followed by in vivo validation. We routinely use cell lines (derived from healthy and diseased individuals as well as commercially available cancer cell lines) and clinical samples to discover and functionally characterize genetic variation and gene, miRNA, and long noncoding RNA expression for their roles in drug sensitivity.
Keywords: R Stephanie Huang; anti-cancer agents; pharmacogenomics; translational.
Similar articles
- Institutional Profile: University of Chicago Center for Personalized Therapeutics: research, education and implementation science.Dolan ME, Maitland ML, O'Donnell PH, Nakamura Y, Cox NJ, Ratain MJ.Dolan ME, et al.Pharmacogenomics. 2013 Sep;14(12):1383-7. doi: 10.2217/pgs.13.134.Pharmacogenomics. 2013.PMID:24024891Free PMC article.
- Clinical translation of cell-based pharmacogenomic discovery.Cox NJ, Gamazon ER, Wheeler HE, Dolan ME.Cox NJ, et al.Clin Pharmacol Ther. 2012 Oct;92(4):425-7. doi: 10.1038/clpt.2012.115. Epub 2012 Aug 22.Clin Pharmacol Ther. 2012.PMID:22910437Free PMC article.Review.
- Progress towards the integration of pharmacogenomics in practice.Mooney SD.Mooney SD.Hum Genet. 2015 May;134(5):459-65. doi: 10.1007/s00439-014-1484-7. Epub 2014 Sep 11.Hum Genet. 2015.PMID:25238897Free PMC article.Review.
- Pharmacogenomics education, research and clinical implementation in the state of Minnesota.Bishop JR, Huang RS, Brown JT, Mroz P, Johnson SG, Allen JD, Bielinski SJ, England J, Farley JF, Gregornik D, Giri J, Kroger C, Long SE, Luczak T, McGonagle EJ, Ma S, Matey ET, Mandic PK, Moyer AM, Nicholson WT, Petry N, Pawloski PA, Schlichte A, Schondelmeyer SW, Seifert RD, Speedie MK, Stenehjem D, Straka RJ, Wachtl J, Waring SC, Ness BV, Zierhut HA, Aliferis C, Wolf SM, McCarty CA, Jacobson PA.Bishop JR, et al.Pharmacogenomics. 2021 Jul;22(11):681-691. doi: 10.2217/pgs-2021-0058. Epub 2021 Jun 17.Pharmacogenomics. 2021.PMID:34137665Free PMC article.Review.
- Global pharmacogenomics: where is the research taking us?Olivier C, Williams-Jones B.Olivier C, et al.Glob Public Health. 2014;9(3):312-24. doi: 10.1080/17441692.2014.887137. Epub 2014 Feb 28.Glob Public Health. 2014.PMID:24580118Review.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous